Glucocorticoid activation of anti-inflammatory macrophages protects against insulin resistance

Nat Commun. 2023 Apr 20;14(1):2271. doi: 10.1038/s41467-023-37831-z.

Abstract

Insulin resistance (IR) during obesity is linked to adipose tissue macrophage (ATM)-driven inflammation of adipose tissue. Whether anti-inflammatory glucocorticoids (GCs) at physiological levels modulate IR is unclear. Here, we report that deletion of the GC receptor (GR) in myeloid cells, including macrophages in mice, aggravates obesity-related IR by enhancing adipose tissue inflammation due to decreased anti-inflammatory ATM leading to exaggerated adipose tissue lipolysis and severe hepatic steatosis. In contrast, GR deletion in Kupffer cells alone does not alter IR. Co-culture experiments show that the absence of GR in macrophages directly causes reduced phospho-AKT and glucose uptake in adipocytes, suggesting an important function of GR in ATM. GR-deficient macrophages are refractory to alternative ATM-inducing IL-4 signaling, due to reduced STAT6 chromatin loading and diminished anti-inflammatory enhancer activation. We demonstrate that GR has an important function in macrophages during obesity by limiting adipose tissue inflammation and lipolysis to promote insulin sensitivity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipose Tissue
  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Glucocorticoids* / pharmacology
  • Inflammation
  • Insulin Resistance* / genetics
  • Macrophages
  • Mice
  • Mice, Inbred C57BL
  • Obesity / genetics

Substances

  • Glucocorticoids
  • Anti-Inflammatory Agents